Skip to main content
Caplight Logo









Qaelon Medical

Qaelon Medical

Private
StrasbourgHealthcare & Life Scienceshttps://www.qaelonmedical.com/

Last Round

Grant

Mar 31, 2026

Total Funding Raised

$30,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Qaelon Medical is a medical device company that develops real-time intraoperative leak detection and advanced constant-flow insufflation technology for minimally invasive and endoluminal surgery.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Healthcare Analytics, Sensors

Business Model

B2B

Customer Profile

Hardware + Subscription, Usage-Based SaaS

AI Layer

Application

Keywords

surgical leak detectionintraoperative diagnosticsconstant-flow insufflationminimally invasive surgerysurgical intelligencemedtechdigital surgeryphysiologic signal analyticsclinical decision supportrobotic surgeryelectronic medical recordEMRreal-time monitoringsmart insufflatorsurgical safetyOR techdigital OR

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Qaelon Medical Comparables

Compare Qaelon Medical with similar companies based on industry and business-model similarity.

Qaelon Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
FluidAI Medical
78%
Exero Medical
70%
Palliare
68%

Qaelon Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 31, 2026

Key People

Founding team and executive leadership

Liam J. Burns

Chief Executive Officer

Executive Team

Yee Ying Douchamps

Chief Operating Officer

Executive Team

Qaelon Medical Investors

Notable investors and investment history

Qaelon Medical investors
InvestorRounds
SEMIASeed
WiSeedSeed
BpifranceGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 93% MoM.

  • Mar 31, 2026

    $30K grant received from Society of American Gastrointestinal and Endoscopic Surgeons.

Qaelon Medical Filings

Explore SEC and related filing metadata, where available.

Qaelon Medical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Qaelon Medical's valuation, stock price, and market status.

Is Qaelon Medical a public or private company?

Qaelon Medical is a private company.

What is the current stock price of Qaelon Medical?

Qaelon Medical is a private company with no public stock price. No recent secondary market data is available.

How much is Qaelon Medical worth (valuation)?

Valuation information for Qaelon Medical is not publicly available.

Can I buy Qaelon Medical stock?

Qaelon Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Qaelon Medical's last funding round?

Qaelon Medical's most recent funding round was Grant on March 31, 2026.

Who are the main investors in Qaelon Medical?

Key investors in Qaelon Medical include Bpifrance.

Will Qaelon Medical IPO soon?

No public IPO plans have been announced for Qaelon Medical.

How can I track Qaelon Medical secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Qaelon Medical's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersStrasbourg
Employee Range3
Year FoundedN/A
Last FundingMar 31, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?